Prolacta logo_singlecolor.png
Prolacta’s 100% Human Milk-Based Fortifiers Lower the Risk of Multiple Complications and Death Among Preterm Infants, Compared to Fortifiers Made From Cow Milk, Says New Study
September 08, 2020 09:05 ET | Prolacta Bioscience
DUARTE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of a new...
Prolacta Bioscience® to Provide Perspective on the Needs of Newborns With Heart Defects
October 25, 2018 08:05 ET | Prolacta Bioscience
DUARTE, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Prolacta Bioscience, the nation’s leading provider of human milk-based neonatal nutritional products to hospitals, will participate in a panel...
Prolacta Bioscience® Doubles Expiration Time and Simplifies Use of Prolact CR® Human Milk-Based Caloric Fortifier
September 20, 2018 09:05 ET | Prolacta Bioscience
DUARTE, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Prolacta Bioscience, the nation’s leading provider of human milk-based neonatal nutritional products to hospitals, announced today that Prolact CR®...
Prolacta Bioscience® Introduces Prolact+6 H2MF® in a New 15 mL Volume
August 22, 2018 09:05 ET | Prolacta Bioscience
DUARTE, Calif., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Prolacta Bioscience, the nation’s leading provider of human milk-based neonatal nutritional products to hospitals, is introducing a new 15 mL option...